Bio Protocol raises $6.9 million in seed funding led by Arthur Hayes' Maelstrom Fund | The Block

Decentralized science (DeSci) protocol Bio has raised $6.9 million after recently rolling out Bio V2, an upgraded platform designed to build an onchain "scientific superintelligence." The funding was led by BitMEX cofounder Arthur Hayes’ family office Maelstrom Fund, with participation from Mechanism Capital, Animoca Brands, Zee Prime Capital, Panga Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, and others, Bio said Wednesday. William Fang, head of strategy at Bio Protocol, told The Block the round is classified as a seed raise. He declined to disclose when fundraising began, when it closed, the round’s structure (equity, tokens, or mix), or the valuation. Fang also declined to share the project’s total funding to date, which includes earlier backing from YZi Labs (formerly Binance Labs) and other investors. As a DeSci protocol, Bio allows scientists to convert their work into decentralized AI agents, or BioAgents. These agents are designed to speed up and reduce the

saved by

• judi aly